Skip to main content
CRYO CELL INTERNATIONAL INC logo

CRYO CELL INTERNATIONAL INC — Investor Relations & Filings

Ticker · CCEL ISIN · US2288951088 LEI · 254900AQWFD6AR2J7Z30 US Human health and social work activities
Open in API
Filings indexed 897 across all filing types
Latest filing 2023-09-15 Annual Report
Country US United States of America
Listing US CCEL

About CRYO CELL INTERNATIONAL INC

https://www.cryo-cell.com/

Cryo-Cell International, Inc. is a biotechnology company specializing in cellular processing and cryogenic storage. Established in 1989 as the world's first private cord blood bank, the company's primary service is the collection, processing, and long-term preservation of stem cells from umbilical cord blood and cord tissue. These services are offered to families for potential future use in treating a wide range of medical conditions. The company is focused on providing high-quality cryopreservation services and contributing to the advancement of regenerative medicine through its support of research and clinical applications.

Recent filings

Filing Released Lang Actions
ARS
Annual Report
2023-09-15 English
DEF 14A
Proxy Solicitation & Information Statement
2023-09-14 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 24, 2023. The content primarily announces the date for the 2023 Annual Meeting of Stockholders and the record date for voting eligibility. It also mentions procedural details about submitting business or director nominations for the meeting. There is no financial data, earnings information, or detailed report content. The document is short (3379 characters) and serves as an announcement related to the Annual General Meeting, but it does not contain the AGM materials or presentations themselves. Therefore, it is not an AGM Information filing (AGM-R). Instead, it is a regulatory announcement about the meeting date and related procedural information, fitting best under Regulatory Filings (RNS).
2023-08-25 English
10-Q
Interim / Quarterly Report Q2 2023
2023-07-14 English
10-Q
Interim / Quarterly Report Q1 2023
2023-04-21 English
NT 10-Q
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC by Cryo-Cell International, Inc. It notifies the SEC that the company was unable to file its Quarterly Report on Form 10-Q for the quarter ended February 28, 2023, by the due date due to delays in completing financial statements and disclosures. The document does not contain the actual financial statements or substantive financial data but is a notification about the delay in filing the report. The document length is 4419 characters, which is relatively short and consistent with a notification rather than a full report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document notifying the SEC of a late filing and does not contain the report itself.
2023-04-14 English

Browse filings by year

30 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.